Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,928 | 39,018 | 99,501 | 87,615 | 102,042 |
| Marketable Securities | 48,083 | 48,408 | N/A | N/A | N/A |
| Receivables | 10,832 | 10,376 | 15,703 | 4,464 | 5,687 |
| Inventories | 2,467 | 2,737 | 2,671 | 2,186 | 1,784 |
| TOTAL | $100,421 | $111,111 | $130,628 | $105,619 | $119,731 |
| Non-Current Assets | |||||
| PPE Net | 4,577 | 3,975 | 3,701 | 2,364 | 2,017 |
| Other Non-Current Assets | 2,390 | 1,781 | 400 | 0 | 0 |
| TOTAL | $6,967 | $5,756 | $4,101 | $2,364 | $2,017 |
| Total Assets | $107,387 | $116,866 | $134,728 | $107,982 | $121,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,643 | 1,362 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,481 | 2,885 | 2,272 | 3,527 | 2,087 |
| Accrued Expenses | 15,289 | 9,178 | 7,783 | 8,042 | 7,529 |
| TOTAL | $32,833 | $19,751 | $18,946 | $21,039 | $16,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,076 | 28,323 | 29,662 | N/A | N/A |
| Deferred Revenues | 6,420 | 6,326 | 8,891 | 9,470 | 6,531 |
| Other Non-Current Liabilities | 679 | 437 | 0 | 0 | 0 |
| TOTAL | $63,410 | $65,435 | $66,929 | $35,754 | $36,366 |
| Total Liabilities | $96,244 | $85,185 | $85,875 | $56,792 | $52,514 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,286 | 113,161 | 113,123 | 112,705 | 112,692 |
| Common Shares | 113 | 113 | 113 | 113 | 113 |
| Retained earnings | -340,774 | -317,862 | -298,574 | -294,168 | -274,162 |
| Other shareholders' equity | -39 | -29 | 0 | 0 | 0 |
| TOTAL | $11,144 | $31,681 | $48,854 | $51,190 | $69,234 |
| Total Liabilities And Equity | $107,387 | $116,866 | $134,728 | $107,982 | $121,748 |